Cerebral Invasive Aspergillosis in a Case of Chronic Lymphocytic Leukemia with Bruton Tyrosine Kinase Inhibitor

Bruton tyrosine kinase (BTK) inhibitors have become an important therapy for untreated and previously treated patients with chronic lymphocytic leukemia (CLL). Despite improved outcomes, rare adverse events, such as invasive fungal infections, have been reported with the use of first-generation BTK...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkharabsheh, Omar, Alsayed, Alhareth, Morlote, Diana M., Mehta, Amitkumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985758/
https://www.ncbi.nlm.nih.gov/pubmed/33567487
http://dx.doi.org/10.3390/curroncol28010081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985758/
https://www.ncbi.nlm.nih.gov/pubmed/33567487
http://dx.doi.org/10.3390/curroncol28010081

Ejemplares similares